Clinical Trial: Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880392) titled 'Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain' on Oct. 08.

Brief Summary: This study evaluates the safety and efficacy of DNN.63.18.040 compared with Tramal(R) for the treatment of moderate to severe pain.

Study Start Date: Oct. 19

Study Type: INTERVENTIONAL

Condition: Acute Pain

Intervention: DRUG: Product DNN.63.18.040

One capsule four times daily for 3 days

DRUG: Tramal(R)

One capsule four times daily for 3 days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ache Laboratorios Farmaceuticos S.A.

Disclaimer: Curated by HT Syndication....